Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
- PMID: 11854515
- PMCID: PMC122341
- DOI: 10.1073/pnas.261704098
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
Abstract
P-selectin facilitates human carcinoma metastasis in immunodeficient mice by mediating early interactions of platelets with bloodborne tumor cells via their cell surface mucins, and this process can be blocked by heparin [Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M. & Varki, A. (2001) Proc. Natl. Acad. Sci. USA 98, 3352-3357]. Here we show similar findings with a murine adenocarcinoma in syngeneic immunocompetent mice but involving a different P-selectin ligand, possibly a sulfated glycolipid. Thus, metastatic spread can be facilitated by tumor cell selectin ligands other than mucins. Surprisingly, L-selectin expressed on endogenous leukocytes also facilitates metastasis in both the syngeneic and xenogeneic (T and B lymphocyte deficient) systems. PL-selectin double deficient mice show that the two selectins work synergistically. Although heparin can block both P- and L-selectin in vitro, the in vivo effect of a single heparin dose given before tumor cells seems to be completely accounted for by blockade of P-selectin function. Thus, L-selectin on neutrophils, monocytes, and/or NK cells has a role in facilitating metastasis, acting beyond the early time points wherein P-selectin mediates interactions of platelet with tumor cells.
Figures





Similar articles
-
Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.Am J Pathol. 1999 Aug;155(2):461-72. doi: 10.1016/S0002-9440(10)65142-5. Am J Pathol. 1999. PMID: 10433939 Free PMC article.
-
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7. doi: 10.1073/pnas.061615598. Proc Natl Acad Sci U S A. 2001. PMID: 11248082 Free PMC article.
-
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.J Clin Invest. 2003 Sep;112(6):853-62. doi: 10.1172/JCI18882. J Clin Invest. 2003. PMID: 12975470 Free PMC article.
-
P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.Braz J Med Biol Res. 2001 Jun;34(6):711-7. doi: 10.1590/s0100-879x2001000600003. Braz J Med Biol Res. 2001. PMID: 11378658 Review.
-
Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans.Semin Thromb Hemost. 2002 Feb;28(1):53-66. doi: 10.1055/s-2002-20564. Semin Thromb Hemost. 2002. PMID: 11885026 Review.
Cited by
-
Platelets increase the proliferation of ovarian cancer cells.Blood. 2012 Dec 6;120(24):4869-72. doi: 10.1182/blood-2012-06-438598. Epub 2012 Sep 10. Blood. 2012. PMID: 22966171 Free PMC article.
-
Lung-Derived Selectins Enhance Metastatic Behavior of Triple Negative Breast Cancer Cells.Biomedicines. 2021 Oct 30;9(11):1580. doi: 10.3390/biomedicines9111580. Biomedicines. 2021. PMID: 34829810 Free PMC article.
-
Cell surface markers in colorectal cancer prognosis.Int J Mol Sci. 2010 Dec 28;12(1):78-113. doi: 10.3390/ijms12010078. Int J Mol Sci. 2010. PMID: 21339979 Free PMC article. Review.
-
CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.Cancer Res. 2011 Jun 1;71(11):3802-11. doi: 10.1158/0008-5472.CAN-11-0519. Epub 2011 Apr 11. Cancer Res. 2011. PMID: 21482678 Free PMC article.
-
Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.Front Oncol. 2018 Jan 15;7:328. doi: 10.3389/fonc.2017.00328. eCollection 2017. Front Oncol. 2018. PMID: 29379771 Free PMC article. Review.
References
-
- Karpatkin S, Pearlstein E. Ann Intern Med. 1981;95:636–641. - PubMed
-
- Gasic G J. Cancer Metastasis Rev. 1984;3:99–114. - PubMed
-
- Fidler I J. Cancer Res. 1990;50:6130–6138. - PubMed
-
- Honn K V, Tang D G, Crissman J D. Cancer Metastasis Rev. 1992;11:325–351. - PubMed
-
- Tanaka N G, Tohgo A, Ogawa H. Invasion Metastasis. 1986;6:209–224. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources